AcrySof IQ Toric A-Code Post-Market Clinical Study

AcrySof IQ Toric A-Code Post-Market Clinical Study

The purpose of this study is to clinically confirm the rotational stability of a modified AcrySof IQ toric intraocular lens (IOL) in a Japanese population.

Patients will be examined pre-operatively to up to 3 years post-operatively. One eligible eye will be selected as a target eye for efficacy analysis. If both eyes are eligible, the eye in which the IOL is implanted first will be selected as the target eye.

Inclusion Criteria:

• Diagnosis of cataracts with planned cataract removal by phacoemulsification
• Calculated lens power within the available range
• Able to sign informed consent and complete all study visits
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Eye conditions as specified in the protocol
• Uncontrolled glaucoma
• Pregnancy, current or planned
• Other protocol-defined exclusion criteria may apply.